The field of neurotechnology stands at the cusp of a revolutionary era, with promising new therapeutics and other ways of improving quality of life. From neuromodulation to brain-computer interfaces, these innovations offer hope for restored functionality, improved mental health, cognitive enhancement, and more. Despite this immense potential and excitement, there lies a formidable barrier: the complex landscape of insurance reimbursement.
